X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
ptld (463) 463
index medicus (414) 414
humans (388) 388
transplantation (276) 276
male (250) 250
female (226) 226
adult (167) 167
disease (163) 163
lymphoproliferative disorders - etiology (155) 155
middle aged (155) 155
epstein-barr-virus (152) 152
child (147) 147
epstein-barr virus (146) 146
rituximab (144) 144
surgery (142) 142
ebv (137) 137
immunosuppression (134) 134
adolescent (132) 132
recipients (125) 125
lymphoma (110) 110
oncology (107) 107
hematology (104) 104
child, preschool (96) 96
posttransplant lymphoproliferative disorder (95) 95
solid-organ transplantation (94) 94
retrospective studies (92) 92
risk factors (92) 92
pediatrics (90) 90
aged (85) 85
post-transplant lymphoproliferative disorder (84) 84
kidney transplantation - adverse effects (82) 82
immunology (75) 75
lymphomas (75) 75
lymphoproliferative disorders - virology (74) 74
therapy (73) 73
infant (71) 71
chemotherapy (69) 69
children (69) 69
health aspects (68) 68
organ transplantation - adverse effects (67) 67
risk (67) 67
viral load (67) 67
posttransplant lymphoproliferative disorders (66) 66
epstein-barr virus infections - complications (65) 65
treatment outcome (65) 65
transplantation of organs, tissues, etc (63) 63
lymphoproliferative disorders - diagnosis (62) 62
prognosis (59) 59
young adult (59) 59
organ transplant recipients (54) 54
risk-factors (54) 54
immunotherapy (53) 53
lymphoproliferative disorders - pathology (53) 53
epstein-barr virus infections - virology (52) 52
lymphoproliferative disorders - drug therapy (52) 52
lymphoproliferative disorders - therapy (52) 52
kidney transplantation (51) 51
herpesvirus 4, human - isolation & purification (49) 49
infection (47) 47
lymphoproliferative disorders - epidemiology (47) 47
transplants & implants (47) 47
cancer (46) 46
follow-up studies (45) 45
herpesvirus 4, human - genetics (44) 44
immunosuppressive agents - therapeutic use (44) 44
liver transplantation - adverse effects (44) 44
lymphocytes (43) 43
posttransplant lymphoproliferative disease (43) 43
time factors (43) 43
analysis (42) 42
epstein-barr virus infections - etiology (42) 42
survival (41) 41
immunosuppressive agents - adverse effects (40) 40
liver-transplantation (40) 40
renal-transplantation (40) 40
hemic and lymphatic diseases (39) 39
incidence (39) 39
epstein–barr virus (38) 38
heart (38) 38
liver transplantation (38) 38
management (37) 37
lymphoproliferative disorders (36) 36
bone-marrow-transplantation (35) 35
lymphoproliferative disorders - immunology (35) 35
pathology (35) 35
postoperative complications (35) 35
lymphoproliferative disorders - mortality (34) 34
organ transplantation (34) 34
stem-cell transplantation (34) 34
care and treatment (33) 33
diagnosis (33) 33
herpesvirus 4, human - immunology (33) 33
stem cells (33) 33
b-cell lymphoma (32) 32
dna, viral - blood (32) 32
epstein-barr virus infections - diagnosis (32) 32
hematopoietic stem cell transplantation - adverse effects (32) 32
disorder (31) 31
epstein-barr virus infections - epidemiology (31) 31
epstein-barr virus infections - immunology (31) 31
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (606) 606
German (8) 8
Japanese (8) 8
Korean (7) 7
Portuguese (6) 6
Spanish (6) 6
French (5) 5
Czech (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Pediatric Blood & Cancer, ISSN 1545-5009, 08/2019, Volume 66, Issue 8, pp. e27803 - n/a
Classic Hodgkin lymphoma post‐transplant lymphoproliferative disorder (HL‐PTLD) has been rarely reported in children, with limited data available to guide... 
HL‐PTLD | solid organ transplant | pediatrics | radiation therapy | ONCOLOGY | HL-PTLD | KIDNEY-TRANSPLANT RECIPIENT | DISEASE | PTLD | HEMATOLOGY | Transplantation of organs, tissues, etc | Chemotherapy | Lymphomas | Radiotherapy | Cancer | Rejection | Grafts | Lymphocytes | Radiation | Remission | Children | Radiation therapy | Lymphoma | Posttransplant lymphoproliferative disorders | Hodgkin's disease
Journal Article
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, ISSN 1555-9041, 05/2019, Volume 14, Issue 5, pp. 751 - 753
Journal Article
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 08/2019
Journal Article
Experimental Hematology and Oncology, ISSN 2162-3619, 09/2017, Volume 6, Issue 1, pp. 26 - 26
Journal Article
Acta Oncologica, ISSN 0284-186X, 07/2019, Volume 58, Issue 7, pp. 1041 - 1047
Background: Fluorine-18-fluorodeoxyglucose positron emission tomography (PET) has an established and central role in diagnosis, staging and response evaluation... 
FDG-PET/CT | DIAGNOSIS | HODGKINS-LYMPHOMA | ONCOLOGY | RITUXIMAB | PTLD | SCAN
Journal Article
ONCOLOGIST, ISSN 1083-7159, 06/2006, Volume 11, Issue 6, pp. 674 - 680
Post-transplant lymphoproliferative disorder is the most common malignancy, with the exception of skin cancer, after solid organ transplantation in adults. The... 
polymorphic PTLD | SOLID-ORGAN TRANSPLANTATION | VIRAL LOAD | LIVER-TRANSPLANTATION | PROGNOSTIC-FACTORS | SINGLE-CENTER | LUNG-TRANSPLANT RECIPIENTS | monomorphic PTLD | SERUM-PROTEIN ELECTROPHORESIS | ONCOLOGY | POSTTRANSPLANT LYMPHOPROLIFERATIVE DISORDERS | DISEASE | PTLD | early lesion | EPSTEIN-BARR-VIRUS
Journal Article
Strahlentherapie und Onkologie, ISSN 0179-7158, 01/2017, Volume 193, Issue 1, pp. 80 - 85
Journal Article
International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 08/2019
Journal Article
Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia, 08/2019
Journal Article
THERAPEUTIC APHERESIS AND DIALYSIS, ISSN 1744-9979, 10/2017, Volume 21, Issue 5, pp. 516 - 518
Journal Article
Oncotarget, ISSN 1949-2553, 01/2019, Volume 10, Issue 4, pp. 437 - 438
Central Nervous System (CNS) lymphoma is a rare presentation of post-transplantation lymphoproliferative disorder (PTLD). This single center retrospective... 
EBV | Mycophenolate | Immunosuppression | Transplantation | CNS-PTLD
Journal Article
Journal of Cutaneous Pathology, ISSN 0303-6987, 05/2019, Volume 46, Issue 5, pp. 358 - 362
Post‐transplant lymphoproliferative disorder (PTLD) is an uncommon complication after solid‐organ transplants and hematopoietic stem cell transplants. Isolated... 
dermatopathology | non‐healing ulcer | Hodgkin‐like PTLD | transplant recipient | post‐transplant lymphoproliferative disorder | Hodgkin-like PTLD | RENAL-TRANSPLANT | post-transplant lymphoproliferative disorder | non-healing ulcer | PATHOLOGY | DERMATOLOGY | Transplantation of organs, tissues, etc | Transplantation | Hematopoietic stem cells
Journal Article
Journal of Clinical and Experimental Hematopathology, ISSN 1346-4280, 2018
Because there are limited clinical reports on the impact of human T-lymphotropic virus type 1 (HTLV-1) on organ transplantation, its effects on the development... 
atypical HAM | organ transplantation | ATL | PTLD | HTLV-1
Journal Article
American Journal of Transplantation, ISSN 1600-6135, 11/2012, Volume 12, Issue 11, pp. 3069 - 3075
Optimal therapy for posttransplant lymphoproliferative disease (PTLD) remains problematic. A phase II trial adding rituximab to a low‐dose cyclophosphamide and... 
EBV | PTLD | Chemotherapy | rituximab | SOLID-ORGAN TRANSPLANTATION | SURVIVAL | SURGERY | RISK-FACTORS | CHEMOIMMUNOTHERAPY | CYCLOPHOSPHAMIDE | INVOLVEMENT | DISORDERS PTLD | ANTIBODY | HISTOLOGY | TRANSPLANTATION | LYMPHOMA | Confidence Intervals | Cyclophosphamide - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Prospective Studies | Follow-Up Studies | Humans | Antibodies, Monoclonal, Murine-Derived - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Child, Preschool | Male | Cyclophosphamide - adverse effects | Transplantation, Homologous | Dose-Response Relationship, Drug | Epstein-Barr Virus Infections - etiology | Female | Child | Lymphoproliferative Disorders - etiology | Prednisone - administration & dosage | Prednisone - adverse effects | Drug Administration Schedule | Risk Assessment | Rituximab | Treatment Outcome | Epstein-Barr Virus Infections - drug therapy | Lymphoproliferative Disorders - pathology | Epstein-Barr Virus Infections - pathology | Disease-Free Survival | Lymphoproliferative Disorders - mortality | Maximum Tolerated Dose | Organ Transplantation - adverse effects | Adolescent | Survival Analysis | Epstein-Barr Virus Infections - mortality | Lymphoproliferative Disorders - drug therapy | Organ Transplantation - methods | Antibodies, Monoclonal, Murine-Derived - adverse effects | Cyclophosphamide | Corticosteroids | Dosage and administration | Prednisone | Epstein-Barr virus | Children | Health aspects | Diseases | Cancer | Clinical trials | Transplants & implants | Medical treatment | Clinical outcomes | Index Medicus
Journal Article
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.